Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gilbert Deray

Showing results (151-160 of 213) with videos related to

Pageof 22
Sort By:
Nature Clinical Practice. Nephrology|January 30, 2008
A case of acute renal failure associated with diffuse infiltrative lymphocytosis syndromeHassane Izzedine, Isabelle Brocheriou, Marc-Antoine Valantin, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|February 28, 2002
Pharmacokinetics and dosage adjustment of rifabutin in a haemodialysis patientNader Bassilios, Vincent Launay-Vacher, Abdel-Aziz Hamani, et al.
European Journal of Radiology|January 9, 2009
Prevalence of nephrogenic systemic fibrosis in renal insufficiency patients: results of the FINEST studyNicolas Janus, Vincent Launay-Vacher, Svetlana Karie, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|June 28, 2007
A benefit for renal function after early switch to liposomal amphotericin B from conventional formulation in empirical antifungal treatmentFrançoise Isnard, Patrick Tilleul, Jean-Philippe Laporte, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|November 10, 2006
Pharmacokinetics of bevacizumab in haemodialysisNathalie Garnier-Viougeat, Olivier Rixe, Gilles Paintaud, et al.
Nephrologie & Therapeutique|August 10, 2006
[Tubular transporters OAT1 and MRP2 and clearance of adefovir]Aude Servais, Philippe Lechat, Noël Zahr, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|June 27, 2006
Loss of podocyte dysferlin expression is associated with minimal change nephropathyHassane Izzedine, Isabelle Brocheriou, Bruno Eymard, et al.
European Journal of Pharmacology|June 8, 2006
Tubular transporters and clearance of adefovirAude Servais, Philippe Lechat, Noël Zahr, et al.
AIDS Reviews|July 21, 2016
Is Tenofovir Alafenamide Safer than Tenofovir Disoproxil Fumarate for the Kidneys?Blandine Aloy, Imane Tazi, Corinne Isnard Bagnis, et al.
Kardiologia Polska|October 13, 2021
Rationale and design of XARENO: XA inhibition in RENal patients with non-valvular atrial fibrillation. Observational registryReinhold Kreutz, Gilbert Deray, Jürgen Floege, et al.
Pageof 22

Showing results (151-160 of 213) with videos related to

Sort By:
Pageof 22
Nature Clinical Practice. Nephrology|January 30, 2008
A case of acute renal failure associated with diffuse infiltrative lymphocytosis syndromeHassane Izzedine, Isabelle Brocheriou, Marc-Antoine Valantin, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|February 28, 2002
Pharmacokinetics and dosage adjustment of rifabutin in a haemodialysis patientNader Bassilios, Vincent Launay-Vacher, Abdel-Aziz Hamani, et al.
European Journal of Radiology|January 9, 2009
Prevalence of nephrogenic systemic fibrosis in renal insufficiency patients: results of the FINEST studyNicolas Janus, Vincent Launay-Vacher, Svetlana Karie, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|June 28, 2007
A benefit for renal function after early switch to liposomal amphotericin B from conventional formulation in empirical antifungal treatmentFrançoise Isnard, Patrick Tilleul, Jean-Philippe Laporte, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|November 10, 2006
Pharmacokinetics of bevacizumab in haemodialysisNathalie Garnier-Viougeat, Olivier Rixe, Gilles Paintaud, et al.
Nephrologie & Therapeutique|August 10, 2006
[Tubular transporters OAT1 and MRP2 and clearance of adefovir]Aude Servais, Philippe Lechat, Noël Zahr, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|June 27, 2006
Loss of podocyte dysferlin expression is associated with minimal change nephropathyHassane Izzedine, Isabelle Brocheriou, Bruno Eymard, et al.
European Journal of Pharmacology|June 8, 2006
Tubular transporters and clearance of adefovirAude Servais, Philippe Lechat, Noël Zahr, et al.
AIDS Reviews|July 21, 2016
Is Tenofovir Alafenamide Safer than Tenofovir Disoproxil Fumarate for the Kidneys?Blandine Aloy, Imane Tazi, Corinne Isnard Bagnis, et al.
Kardiologia Polska|October 13, 2021
Rationale and design of XARENO: XA inhibition in RENal patients with non-valvular atrial fibrillation. Observational registryReinhold Kreutz, Gilbert Deray, Jürgen Floege, et al.
Pageof 22